Repurposing Finasteride and Serotonin Reuptake Inhibitors as Novel Antimicrobials: A Dual-Action Approach to Target Bacterial and Fungal Pathogens

These findings underscore the potential of serotonin reuptake inhibitors and finasteride as candidates for antimicrobial repurposing. By impairing both microbial viability and pathogenicity, these drugs may provide promising avenues for developing adjunct or alternative therapies against resistant bacterial and fungal pathogens.